Prostate-Specific Membrane Antigen PET for Patients With Postoperative Recurrence of Prostate Cancer

When it comes to prostate cancer, we have long been torn between the Charybdis and Scylla of overtreatment and undertreatment. The study by Belliveau et al,1 published in JAMA Oncology, attempts to navigate such a path forward in the postoperative space.